Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. RMD open. 2020;6(3).
28/02/2022
Michelsen B, Lindström U, Codreanu C, Ciurea A, Zavada J, Loft AG, et al.
Epub 2020/09/21. doi: 10.1136/rmdopen-2020-001280. PubMed PMID: 32950963.